Molecular basis of allosteric regulation and pharmaceutical targeting of protein kinase Cβ

Abstract Protein kinase C (PKC) isozymes are ubiquitous kinases that direct diverse cellular pathways and are important drug targets for the treatment of cancer and neurological diseases. PKCs are auto-regulating enzymes governed by phospholipid and Ca 2+ signals via a mechanism that has remained enigmatic due to a paucity of structural information. Herein we present a series of structures of the full-length human PKCβI and PKCβII isozymes. These structures reveal the molecular basis by which PKCs maintain an auto-inhibited state, convert to a defined and ordered active conformation via a “lipid-lever” mechanism of allosteric activation, and how isoform-specific differences alter their allosteric regulatory mechanisms. We show that endoxifen, a recently identified PKCβI inhibitor, can alter the allosteric regulatory mechanism of PKCβI, providing a proof of concept for allosteric regulators of PKCs. Collectively, our data describe a foundational molecular model of second messenger-mediated allosteric regulation of PKCs that underpins PKC function, misregulation, and mechanisms of inhibition.

Authors

Institutions

Publication Details

Journal
Nature Communications
Published
2026-05-21
DOI
https://doi.org/10.1038/s41467-026-73413-5
Primary Topic
Protein Kinase Regulation and GTPase Signaling
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Molecular basis of allosteric regulation and pharmaceutical targeting of protein kinase Cβ

Matthew J. Schellenberg, Sayantani Sarkar Bhattacharya, Taylor L. Witter, Anh Cong et al.
Nature Communications
Protein Kinase Regulation and GTPase Signaling
article

Molecular basis of allosteric regulation and pharmaceutical targeting of protein kinase Cβ

Matthew J. Schellenberg, Sayantani Sarkar Bhattacharya, Taylor L. Witter, Anh Cong, John R. Hawse, Swaathi Jayaraman, Jasmina Paluncic, Maria Dugan, Alan P. Fields, Elizabeth S. Bruinsma, Julia R Alvey, Mary J. Kuffel, Huy V. Huynh, Jasper K. Solverson, Akhilesh Pandey, Samuel R. Wyatt, Xinyan Wu, Matthew P. Goetz
article en

Abstract

Abstract Protein kinase C (PKC) isozymes are ubiquitous kinases that direct diverse cellular pathways and are important drug targets for the treatment of cancer and neurological diseases. PKCs are auto-regulating enzymes governed by phospholipid and Ca 2+ signals via a mechanism that has remained enigmatic due to a paucity of structural information. Herein we present a series of structures of the full-length human PKCβI and PKCβII isozymes. These structures reveal the molecular basis by which PKCs maintain an auto-inhibited state, convert to a defined and ordered active conformation via a “lipid-lever” mechanism of allosteric activation, and how isoform-specific differences alter their allosteric regulatory mechanisms. We show that endoxifen, a recently identified PKCβI inhibitor, can alter the allosteric regulatory mechanism of PKCβI, providing a proof of concept for allosteric regulators of PKCs. Collectively, our data describe a foundational molecular model of second messenger-mediated allosteric regulation of PKCs that underpins PKC function, misregulation, and mechanisms of inhibition.

Nature Communications
Mayo Clinic (US), Manipal Academy of Higher Education (IN), Mayo Clinic in Arizona (US), Mayo Clinic in Florida (US)
National Institutes of Health
Good health and well-being
Openalex Percentile: Top 9%
Protein Kinase Regulation and GTPase Signaling
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.